심방세동 수술 시장(2026-2030년)

The global atrial fibrillation surgery market is forecasted to grow by USD 3021.6 mn during 2025-2030, accelerating at a CAGR of 16.8% during the forecast period. The report on the global atrial fibrillation surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancement of ablation and electrophysiology technologies, expansion of specialized cardiac care infrastructure, rising prevalence of atrial fibrillation and cardiovascular disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global atrial fibrillation surgery market is segmented as below:

By Product

• Catheter ablation
• Surgical ablation

By End-User

• Hospitals
• Ambulatory surgical centers
• Others

By Type

• Minimally invasive surgery
• Traditional open surgery
• Hybrid surgery

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the transition toward non thermal energy treatment approaches as one of the prime reasons driving the global atrial fibrillation surgery market growth during the next few years. Also, expansion of multidisciplinary atrial fibrillation management pathways and increasing use of longitudinal digital patient monitoring will lead to sizable demand in the market.

The report on the global atrial fibrillation surgery market covers the following areas:

• Global atrial fibrillation surgery market sizing
• Global atrial fibrillation surgery market forecast
• Global atrial fibrillation surgery market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global atrial fibrillation surgery market vendors that include Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Becton Dickinson and Co., BIOTRONIK SE and Co. KG, Boston Scientific Corp., CardioFocus Inc., Integer Holdings Corp., Johnson and Johnson MedTech, Kardium Inc., LivaNova PLC, Medtronic Plc, MicroPort Scientific Corp., OSYPKA AG, Siemens Healthineers AG, Stereotaxis Inc., Stryker Corp., Toray Industries Inc.. Also, the global atrial fibrillation surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Atrial Fibrillation Surgery Market 2020 - 2024
  • Historic Market Size - Data Table on Global Atrial Fibrillation Surgery Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global atrial fibrillation surgery market
• 6.2 Impact of geopolitical conflicts on global atrial fibrillation surgery market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Catheter ablation - Market size and forecast 2025-2030
• 8.4 Surgical ablation - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Type

• 10.1 Market segments
• 10.2 Comparison by Type
• 10.3 Minimally invasive surgery - Market size and forecast 2025-2030
• 10.4 Traditional open surgery - Market size and forecast 2025-2030
• 10.5 Hybrid surgery - Market size and forecast 2025-2030
• 10.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Advancement of ablation and electrophysiology technologies
  • Expansion of specialized cardiac care infrastructure
  • Rising prevalence of atrial fibrillation and cardiovascular disorders
• 13.2 Market challenges
  • High procedure costs and reimbursement limitations
  • Shortage of specialized clinical expertise
  • Clinical variability and risk of treatment recurrence
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Transition toward non thermal energy treatment approaches
  • Expansion of multidisciplinary atrial fibrillation management pathways
  • Increasing use of longitudinal digital patient monitoring

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 AngioDynamics Inc.
  • AngioDynamics Inc. - Overview
  • AngioDynamics Inc. - Business segments
  • AngioDynamics Inc. - Key offerings
  • AngioDynamics Inc. - Segment focus
  • SWOT
• 15.6 AtriCure Inc.
  • AtriCure Inc. - Overview
  • AtriCure Inc. - Product / Service
  • AtriCure Inc. - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 BIOTRONIK SE and Co. KG
  • BIOTRONIK SE and Co. KG - Overview
  • BIOTRONIK SE and Co. KG - Product / Service
  • BIOTRONIK SE and Co. KG - Key offerings
  • SWOT
• 15.9 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.10 CardioFocus Inc.
  • CardioFocus Inc. - Overview
  • CardioFocus Inc. - Product / Service
  • CardioFocus Inc. - Key offerings
  • SWOT
• 15.11 Integer Holdings Corp.
  • Integer Holdings Corp. - Overview
  • Integer Holdings Corp. - Business segments
  • Integer Holdings Corp. - Key offerings
  • Integer Holdings Corp. - Segment focus
  • SWOT
• 15.12 Johnson and Johnson MedTech
  • Johnson and Johnson MedTech - Overview
  • Johnson and Johnson MedTech - Product / Service
  • Johnson and Johnson MedTech - Key offerings
  • SWOT
• 15.13 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 15.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.15 MicroPort Scientific Corp.
  • MicroPort Scientific Corp. - Overview
  • MicroPort Scientific Corp. - Business segments
  • MicroPort Scientific Corp. - Key offerings
  • MicroPort Scientific Corp. - Segment focus
  • SWOT
• 15.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.17 Stryker Corp.
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Segment focus
  • SWOT
• 15.18 Toray Industries Inc.
  • Toray Industries Inc. - Overview
  • Toray Industries Inc. - Business segments
  • Toray Industries Inc. - Key news
  • Toray Industries Inc. - Key offerings
  • Toray Industries Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations